Claraphi Advisory Network, LLC Invitae Corp Transaction History

Claraphi Advisory Network, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $367,153 - $507,460	-15,103 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $407,369 - $630,805	-15,614 Reduced 50.83%	15,103 $509,000
Q1 2021 Apr 30, 2021	SELL	$33.06 - $56.93 $73,294 - $126,213	-2,217 Reduced 6.73%	30,717 $1.17 Million
Q4 2020 Feb 05, 2021	BUY	$39.09 - $57.4 $447,932 - $657,746	11,459 Added 53.36%	32,934 $1.38 Million
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $157,985 - $248,231	5,557 Added 34.91%	21,475 $931,000
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $186,399 - $482,156	15,918 New	15,918 $482,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Claraphi Advisory Network, LLC with notifications on news.